SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: synchro who wrote (389)7/4/1999 10:30:00 AM
From: Dave Chanoux  Read Replies (1) of 410
 
I'm still here and still holding my tracking stocks. You are right that they give the company a vehicle to push the losses off the Genzyme books, but the amounts are pretty small. Small but probably significant.

I remember an offer to take the odd-lot Tissue Repair shares off the statement for a fee, but did not take advantage of it. The last two have higher value. But my position is hold for lack of interest.

Regards,

Dave Chanoux
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News